BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20803149)

  • 1. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.
    Chopra A; Iyer VK; Agarwala S; Mathur SR; Aron M; Gupta SD; Verma K
    Pediatr Surg Int; 2010 Dec; 26(12):1173-8. PubMed ID: 20803149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
    Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
    Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.
    Zerbini MC; Sredni ST; Grier H; Cristofani LM; Latorre MR; Hollister KA; Alves VA; Weinberg DS; Perez-Atayde AR
    Pediatr Dev Pathol; 1998; 1(4):270-80. PubMed ID: 10463288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
    Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
    Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric evaluation of nuclear DNA content in hepatoblastoma: further evidence for the inhomogeneity of the different subtypes.
    Kröber S; Ruck P; Xiao JC; Kaiserling E
    Pathol Int; 1995 Jul; 45(7):501-5. PubMed ID: 7551010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
    Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
    Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of the nuclear DNA content of hepatoblastoma.
    Hata Y; Ishizu H; Ohmori K; Hamada H; Sasaki F; Uchino J; Inoue K; Naitoh H; Fujita M; Kobayashi T
    Cancer; 1991 Dec; 68(12):2566-70. PubMed ID: 1657362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
    Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
    Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma.
    Halász J; Holczbauer A; Páska C; Kovács M; Benyó G; Verebély T; Schaff Z; Kiss A
    Hum Pathol; 2006 May; 37(5):555-61. PubMed ID: 16647953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma.
    Park WS; Oh RR; Park JY; Kim PJ; Shin MS; Lee JH; Kim HS; Lee SH; Kim SY; Park YG; An WG; Kim HS; Jang JJ; Yoo NJ; Lee JY
    J Pathol; 2001 Apr; 193(4):483-90. PubMed ID: 11276007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
    Staibano S; Mignogna MD; Lo Muzio L; Di Alberti L; Di Natale E; Lucariello A; Mezza E; Bucci E; DeRosa G
    Hum Pathol; 1998 Nov; 29(11):1189-94. PubMed ID: 9824094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma.
    Hino Y; Kohashi K; Tamaki A; Kawakubo N; Hamada H; Fukuhara M; Shibui Y; Tajiri T; Oda Y
    Pathol Res Pract; 2024 Jun; 258():155348. PubMed ID: 38761648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
    Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
    J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tricellulin expression is associated with better survival in human hepatoblastoma.
    Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
    Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J; Kirchner B; Eicher C; Warmann SW; Seitz G; Fuchs J; Armeanu-Ebinger S
    Pediatr Blood Cancer; 2010 Dec; 55(6):1089-95. PubMed ID: 20680965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
    Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
    Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy as a prognostic factor in rhabdomyosarcoma. Analysis of 35 cases with image cytometry.
    Pohar-Marinsek Z; Bracko M; Lavrencak J; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Aug; 25(4):235-42. PubMed ID: 12961831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I; Une Y; Uchino J
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.